Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$15.03 - $35.96 $195,390 - $467,480
13,000 New
13,000 $467,000
Q2 2022

Jul 25, 2022

SELL
$11.81 - $20.92 $25,982 - $46,024
-2,200 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$16.0 - $28.84 $35,200 - $63,448
2,200 New
2,200 $44,000

Others Institutions Holding IMGO

About Imago BioSciences, Inc.


  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.